Emerging drugs for the treatment of anxiety. Expert Opin Emerg Drugs. 2015; 20(3):393-406. Epub 2015/05/28. https://doi.org/10.1517/14728214.2015. 1049996 PMID: 26012843; PubMed Central PMCID: PMCPMC4869976.Murrough J W; Yaqubi S; Sayed S;.Emerging drugs for the treatment of anxiety....
- Company 22 - The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aureus (including MRSA)- Company 23 - Drugs for the treatment of depression, anxiety, epilepsy, pain, glaucoma, spasticity, and a ...
Though there was initial interest in the use of psychedelic drugs for psychiatric treatment, bad outcomes and subsequent passage of the Substance Act of 1970, which placed psychedelic drugs in the Schedule I category, significantly limited potential progress. More recently, however, there has been re...
Jaturapatporn D, Isaac MGEKN, McCleery J, Tabet N: Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer’s disease. 2012, Library: The Cochrane Google Scholar Pre-publication history The pre-publication history for this paper can be accessed here:http:...
Therefore, many researchers believe that the development of drugs for the treatment of T2DM may help improve the pathological conditions of AD. Studies have found that geniposide, as a glucagon-like peptide-1 receptor agonist, has a sig- nificant effect on improving the pathological process of ...
(ADME) of drugs. Conversely, drugs can also modulate the composition and function of gut microbiota, leading to changes in microbial metabolism and immune response. We also discuss the practical challenges, strategies, and opportunities in this field, emphasizing the critical need to develop an ...
reserved as a last resort, mainstay pharmacologic treatments for UC are immunosuppressant drugs and biologics, which reduce the number and severity of disease flares. To reduce the risk of adverse side effects, emerging therapies are geared toward providing pain relief in a targeted, site-specific ...
There is currently no cure for AS, but advancements in small molecule drugs and gene therapies offer a promising approach for the treatment of the disorder. Here, we review AS and how loss-of-function of the maternal UBE3A contributes to the disorder. We also discuss the strengths and ...
The public is often well-versed in the potential harms of psychedelic drugs, but much of this knowledge is from cases involving patients who used illicit substances in unsupervised nonmedical contexts. We discuss the emerging research for therapeutic purposes involving human subjects, considering both ...
Dysregulation of various cells in the tumor microenvironment (TME) causes immunosuppressive functions and aggressive tumor growth. In combination with immune checkpoint blockade (ICB), epigenetic modification-targeted drugs are emerging as attractive can